Miliary tuberculosis following intravesical Bacillus Calmette and Guérin therapy: A rare complication of a frequent procedure.
BCG, Bacillus Calmette-Guerin
Bladder cancer
CT, Computed Tomography
EORTC, European Organisation for Research and Treatment of Cancer
Intravesical BCG
Miliary pulmonary tuberculosis
Mycobacterium bovis
PCR, polymerase chain reaction
TUR, Transurethral Resection
Journal
Urology case reports
ISSN: 2214-4420
Titre abrégé: Urol Case Rep
Pays: United States
ID NLM: 101626357
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
03
03
2021
revised:
18
03
2021
accepted:
20
03
2021
entrez:
19
4
2021
pubmed:
20
4
2021
medline:
20
4
2021
Statut:
epublish
Résumé
The standard treatment for superficial vesical tumors is transurethral resection (TUR) followed by intravesical instillation of Bacillus Calmette and Guérin (BCG). Pulmonary complications of BCG-therapy are rare but could be life threatening. We report the case of a 54-year-old patient who received BCG-therapy after TUR. After the sixth session of BCG instillations, the patient was diagnosed with a miliary tuberculosis secondary to BCG-therapy. We observed a progressive clinical and radiological improvement under specific tuberculosis treatment. Early diagnosis of pulmonary side effects of BCG-therapy and prompt treatment are the keys to complete recovery and survival.
Identifiants
pubmed: 33868941
doi: 10.1016/j.eucr.2021.101655
pii: S2214-4420(21)00095-4
pmc: PMC8040259
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101655Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
None.
Références
Medicine (Baltimore). 2014 Oct;93(17):236-254
pubmed: 25398060
Intern Med. 2017;56(12):1563-1567
pubmed: 28626185
Eur Urol. 2014 Jan;65(1):69-76
pubmed: 23910233
Eur Urol. 2000;37 Suppl 1:21-5
pubmed: 10575268
Immunotargets Ther. 2020 Feb 13;9:1-11
pubmed: 32104666